MedWatch

On 24 occasions employees warned Lundbeck management of foul play

Lundbeck's whistleblower scheme has been used more than 20 times. Some of these cases had direct consequences.

Chairman of Lundbeck's Board Lars Rasmussen | Photo: Gregers Tycho/ERH

Pharmaceutical company Lundbeck's employees have warned the firm's upper management of foul play on 24 occasions, and in several of these cases this event has led to direct consequences.

In 2020, Lundbeck received 24 reports from coworkers, and 22 of these have been concluded by now.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs